Pharmaresearch Bio Co (XKRX:217950) Other Long Term Assets : ₩1,719 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Other Long Term Assets?

Pharmaresearch Bio Co's other long-term assets for the quarter that ended in Dec. 2024 was ₩1,719 Mil.

Pharmaresearch Bio Co's quarterly other long-term assets declined from Dec. 2022 (₩4,063 Mil) to Dec. 2023 (₩1,752 Mil) but then stayed the same from Dec. 2023 (₩1,752 Mil) to Dec. 2024 (₩1,719 Mil).

Pharmaresearch Bio Co's annual other long-term assets declined from Dec. 2022 (₩4,063 Mil) to Dec. 2023 (₩1,752 Mil) and declined from Dec. 2023 (₩1,752 Mil) to Dec. 2024 (₩1,719 Mil).

Pharmaresearch Bio Co Other Long Term Assets Historical Data

The historical data trend for Pharmaresearch Bio Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Other Long Term Assets Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

120.76

506.59

4,062.99

1,751.84

1,719.15

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Other Long Term Assets	Get a 7-Day Free Trial			120.76	506.59	4,062.99	1,751.84	1,719.15

Pharmaresearch Bio Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines